-- Novartis, Schulthess Group, SGS May Be Active: Swiss Equity Market Preview
-- Adam Haigh
-- 2010-07-15T06:27:35Z
-- http://www.bloomberg.com/news/2010-07-15/novartis-schulthess-group-sgs-may-be-active-swiss-equity-market-preview.html

          
          
             The following companies’ shares may
be active in Zurich. Stock symbols are in parentheses after
company names. Prices are from the last close.  
 The Swiss Market Index of the biggest and most actively
traded companies rose 33.69, or 0.5 percent, to 6,332.28. The
broader Swiss Performance Index increased 0.4 percent to
5,591.4.  
 Novartis AG  (NOVN VX): The company reported higher second-
quarter profit as doctors prescribed more of the company’s new
medicines to treat eye disease and high blood pressure.  
 Net income rose 19 percent to $2.42 billion from $2.04
billion a year earlier, the Basel, Switzerland-based company
said today in an e-mailed statement. Analysts expected profit
of $2.43 billion, according to the average of 14 estimates
compiled by Bloomberg over the past month. The stock gained 1.5
percent to 53.75 Swiss francs.  
 Schulthess Group  (SGRN SW): The company said first-half
sales fell to 139.6 million Swiss francs from 162 million
francs the year earlier. The shares fell 0.6 percent to 35.3
francs.  
 SGS SA  (SGSN VX): The world’s biggest goods inspector said
it expects profit and sales this year to beat 2009’s results
after demand for its consumer- and mineral-testing services
increased in the first half. The stock climbed 2.3 percent to
1,585 francs.  
 To contact the reporter on this story:
Adam Haigh in London at 
 ahaigh1@bloomberg.net   
          
          


  


        